PXI Auto Components
301560
Shenzhen Crastal Technology
300824
Shenzhen Zesum Technology
301486
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
CN Stock MarketDetailed Quotes
603669 Lionco Pharmaceutical Group
- 4.38
- -0.24-5.19%
Market Closed Apr 25 15:00 CST
3.16BMarket Cap-24.20P/E (TTM)
4.55High4.34Low454.66KlotVolume4.53Open4.62Pre Close201.01MTurnover6.30%Turnover RatioLossP/E (Static)721.24MShares9.5452wk High4.46P/B3.16BFloat Cap3.4552wk Low5.08Limit Up721.24MShs Float20.05Historical High4.16Limit Down4.55%Amplitude2.94Historical Low--Dividend TTM4.42Avg Price210.55KlotAsk--Div YieldTTM100Lot Size215.36KlotBid
Lionco Pharmaceutical Group News
Lingkang Pharmaceutical: Announcement on the results of the optional resale of “Lingkang Bonds Transfer”
Lingkang Pharmaceutical: 9th indicative announcement on the optional resale of “Lingkang Debt Transfer”
Lingkang Pharmaceutical: Seventh indicative announcement on the optional resale of “Lingkang Bonds Transfer”
Lingkang Pharmaceutical: Sixth indicative announcement on the optional resale of “Lingkang Bonds Transfer”
Lingkang Pharmaceutical: Fifth indicative announcement on the optional resale of “Lingkang Debt Transfer”
Lingkang Pharmaceutical: Third indicative announcement on the optional resale of “Lingkang Debt Transfer”
Lingkang Pharmaceutical: Second indicative announcement on the optional resale of “Lingkang Debt Transfer”
Lingkang Pharmaceutical: First indicative announcement on the option to resell “Lingkang Debt Transfer”
Lingkang Pharmaceutical: Announcement on the optional resale of “Lingkang Bonds Transfer”
Lingkang Pharmaceutical: Convertible Corporate Bond Interest Payment Notice
Lingkang Pharmaceutical: 2021 Annual Equity Distribution Implementation Notice
Lingkang Pharmaceutical: Announcement on the tracking rating results of “Lingkang Convertible Bonds” in 2022
Lingkang Pharmaceutical Group Co., Ltd. principal and “Lingkang Convertible Bonds” 2022 tracking rating report
Announcement on the tracking rating results of “Lingkang Convertible Bonds” in 2022
Lingkang Pharmaceutical: Convertible Corporate Bond Interest Payment Announcement
Lingkang Pharmaceutical: Announcement on the 2021 tracking rating results of “Lingkang Convertible Bonds”
Lingkang Pharmaceutical: Lingkang Pharmaceutical Group Co., Ltd. Entity and “Lingkang Convertible Bonds” 2021 Annual Tracking Rating Report
Lingkang Pharmaceutical: Credit Rating Report on Publicly Issued Convertible Corporate Bonds
Lingkang Pharmaceutical: Online Roadshow Announcement on the Public Issuance of Convertible Corporate Bonds
Lingkang Pharmaceutical: Response Report to the “Letter on Preparing for the Development and Review Committee Meeting on the Public Issuance of Convertible Corporate Bonds by Lingkang Pharmaceutical Group Co., Ltd.” (Revised Draft)